196 related articles for article (PubMed ID: 31412007)
1. Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer.
Li R; Duplisea JJ; Petros FG; González GMN; Tu SM; Karam JA; Huynh TT; Ward JF
Eur Urol Oncol; 2021 Aug; 4(4):651-658. PubMed ID: 31412007
[TBL] [Abstract][Full Text] [Related]
2. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
3. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
4. A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
Leão R; Nayan M; Punjani N; Jewett MAS; Fadaak K; Garisto J; Lewin J; Atenafu EG; Sweet J; Anson-Cartwright L; Boström P; Chung P; Warde P; Bedard PL; Bagrodia A; Freifeld Y; Power N; Winquist E; Hamilton RJ
Eur Urol Focus; 2018 Dec; 4(6):995-1001. PubMed ID: 29428550
[TBL] [Abstract][Full Text] [Related]
5. External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancer.
Paffenholz P; Nestler T; Hoier S; Pfister D; Hellmich M; Heidenreich A
Urol Oncol; 2019 Nov; 37(11):809.e9-809.e18. PubMed ID: 31540832
[TBL] [Abstract][Full Text] [Related]
6. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
7. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
Ghoreifi A; Mitra AP; McClintock G; Baky F; McDowell Z; Lavallée E; Saoud R; Cai J; Gill IS; Sfakianos J; Porter J; Bagrodia A; Ahmadi N; Eggener S; Ward JF; Djaladat H
Urol Oncol; 2023 Feb; 41(2):111.e7-111.e14. PubMed ID: 36437156
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Antonelli L; Ardizzone D; Tachibana I; Adra N; Cary C; Hugar L; Sexton WJ; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Cazzaniga W; Nicol D; Gerdtsson A; Tandstad T; Fizazi K; Fankhauser CD;
J Clin Oncol; 2023 Dec; 41(34):5296-5305. PubMed ID: 37656935
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
[TBL] [Abstract][Full Text] [Related]
11. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
[TBL] [Abstract][Full Text] [Related]
12. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
[TBL] [Abstract][Full Text] [Related]
13. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
14. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
[TBL] [Abstract][Full Text] [Related]
15. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience.
Kamel MH; Littlejohn N; Cox M; Eltahawy EA; Davis R
J Endourol; 2016 May; 30(5):510-9. PubMed ID: 26669219
[TBL] [Abstract][Full Text] [Related]
16. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
17. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
[TBL] [Abstract][Full Text] [Related]
18. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
Nestler T; Paffenholz P; Pfister D; Schoch J; Nini A; Hiester A; Albers P; Heidenreich A
J Urol; 2024 Mar; 211(3):426-435. PubMed ID: 38085711
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
